Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structures and membrane interactions of human OAT1 in complex with clinical used drugs. | Sci Adv | 2025 | 39951534 | PubTator, text mining | PubMed |
| Comparative analysis of the physiological and transport functions of various sources of renal proximal tubule cells under static and fluidic conditions in PhysioMimix T12 platform. | Drug Metab Dispos | 2025 | 39884810 | PubTator, text mining | PubMed |
| Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes. | Pharmaceuticals (Basel) | 2025 | 39861105 | PubTator, text mining | PubMed |
| Luciferase-based bioluminescence revealed the facilitated diffusion of D-luciferin mediated by SLC17A3. | Biochem Biophys Res Commun | 2025 | 39837223 | PubTator, text mining | PubMed |
| Clinical Assessment of Drug Transporter Inhibition Using Biomarkers: Review of the Literature (2015-2024). | J Clin Pharmacol | 2025 | 39828904 | PubTator, text mining | PubMed |
| Optimizing gout treatment: A comprehensive review of current and emerging uricosurics. | Joint Bone Spine | 2025 | 39622367 | PubTator, text mining | PubMed |
| Mechanisms of levan in ameliorating hyperuricemia: Insight into levan on serum metabolites, gut microbiota, and function in hyperuricemia rats. | Carbohydr Polym | 2025 | 39486924 | PubTator, text mining | PubMed |
| 7-Hydroxycoumarin and its conjugated metabolites interact with organic anion transporters 1 and 3 in vitro and in vivo. | Chem Biol Interact | 2025 | 39481674 | PubTator, text mining | PubMed |
| New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans. | Clin Pharmacol Ther | 2025 | 39148267 | PubTator, text mining | PubMed |
| Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions. | J Adv Res | 2025 | 38609050 | PubTator, text mining | PubMed |
| Transiently elevated expression of different forms of brain-derived neurotrophic factor in the neonatal medial prefrontal cortex affected anxiety and depressive-like behaviors in adolescence. | PeerJ | 2024 | 39619203 | PubTator, text mining | PubMed |
| Recent Advances on the Regulations of Organic Anion Transporters. | Pharmaceutics | 2024 | 39598479 | PubTator, text mining | PubMed |
| Korean Red Ginseng Ameliorates the Level of Serum Uric Acid via Downregulating URAT1 and Upregulating OAT1 and OAT3. | Biol Pharm Bull | 2024 | 39551525 | PubTator, text mining | PubMed |
| Reimagining the meninges from a neuroimmune perspective: a boundary, but not peripheral. | J Neuroinflammation | 2024 | 39548515 | PubTator, text mining | PubMed |
| Cladophora glomerata Kützing extract exhibits antioxidant, anti-inflammation, and anti-nitrosative stress against impairment of renal organic anion transport in an in vivo study. | Nutr Res Pract | 2024 | 39398884 | PubTator, text mining | PubMed |
The impact of freeze-dried Baiyedancong-Oolong tea aqueous extract containing bioactive compounds on the activities of CYP450 enzymes, the transport capabilities of P-gp and OATs, and transcription levels in mice. | Food Nutr Res | 2024 | 39376904 | PubTator, text mining | PubMed |
| In vitro and in silico characterization of the transport of selected perfluoroalkyl carboxylic acids and perfluoroalkyl sulfonic acids by human organic anion transporter 1 (OAT1), OAT2 and OAT3. | Toxicology | 2024 | 39343156 | PubTator, text mining | PubMed |
| Organic anion transporters in remote sensing and organ crosstalk. | Pharmacol Ther | 2024 | 39284369 | PubTator, text mining | PubMed |
| Lack of effects of polystyrene micro- and nanoplastics on activity and expression of human drug transporters. | Environ Toxicol Pharmacol | 2024 | 39260711 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy. | Cell Rep Med | 2024 | 39168099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=4